Stephens & Co. Maintains Overweight on Bio-Techne, Adjusts Price Target to $105 – 4-for-1 Stock Split

Stephens & Co. analyst Jacob Johnson maintains Bio-Techne (NASDAQ:TECH) with a Overweight, adjusts price target to $105 – 4-for-1 stock split.